top of page

At-Home Metabolomics Test: Catch Disease Early | Dr Paniz Jasbi

Writer: Matthew Coffman
Matthew Coffman
Jul 28, 2023
44 min read

Updated: 2 days ago

Dr. Paniz Jasbi, founder of Theriome, joins Matthew Coffman to explain metabolomics and the company's at-home Aristotle test. Paniz describes finishing his doctoral work at Arizona State University's College of Health Solutions and noticing a gap between what a research lab can measure and what a typical clinic visit reports.


The Aristotle test, as he describes it, is a direct-to-consumer dry blood spot metabolomics panel run with gas chromatography and mass spectrometry. He says it monitors 126 metabolites, rolls them into 12 scored health indices, and can be followed by a consult with one of Theriome's clinicians. He also previews later tests, including a stool-based BioMe assay. The site he gives is therio.me.



Listen on this page




Listen on your platform




Chapters


  • 0:01 Integrative Thoughts open and midroll ads

  • 2:54 Today's guest is Dr. Paniz Jasbi

  • 4:48 Conversation starts

  • 5:32 From an ASU lab to founding Theriome

  • 8:00 The Aristotle metabolomics test

  • 8:54 Limits of standard yearly blood testing

  • 12:06 At-home results and a consult with their clinicians

  • 20:36 Twelve health indices, including an environmental toxin score

  • 27:42 How 126 metabolites become a 1-to-10 score

  • 35:25 From early detection to optimizing scores

  • 48:29 How the dry blood spot kit works at home

  • 54:06 How often to retest

  • 1:08:16 Where to find Theriome



About this episode


Dr. Paniz Jasbi, founder of Theriome, joins Matthew Coffman to explain metabolomics and the company's at-home Aristotle test. Paniz describes finishing his doctoral work at Arizona State University's College of Health Solutions and noticing a gap between what a research lab can measure and what a typical clinic visit reports.


The Aristotle test, as he describes it, is a direct-to-consumer dry blood spot metabolomics panel run with gas chromatography and mass spectrometry. He says it monitors 126 metabolites, rolls them into 12 scored health indices, and can be followed by a consult with one of Theriome's clinicians. He also previews later tests, including a stool-based BioMe assay. The site he gives is therio.me.



Why listen


Listen if you want a clear walkthrough of at-home metabolomics testing, what Theriome's 12 scores are trying to show, and how the dry blood spot kit actually works.



Key takeaways


  • Paniz founded Theriome after doctoral work at ASU, with the goal of bringing research-lab metabolomics to a test people can do at home.

  • He describes Aristotle as a dry blood spot metabolomics panel of 126 metabolites, analyzed with gas chromatography and mass spectrometry, and says it is built to yield far more information than a standard yearly blood panel.

  • Results are also summarized as 12 health indices scored from 1 to 10, including neurocognitive, liver, cardiovascular, aging, mitochondrial, gut, and environmental toxin exposure scores. Customers can book a consult with Theriome MDs, RDs, or PhDs.

  • He shares a case in which diet changes were suggested and a later retest showed a gut health score moving from 2 to 8, and he recommends one to three tests a year for routine monitoring, with some customers testing more often.

  • The kit ships to your home with graphic instructions, written steps, and a QR code to a how-to video. Paniz points people to therio.me and info@therio.me.



Mentioned in this episode





Timestamps follow the published podcast audio.



0:01 Integrative Thoughts open and midroll ads


Hello, everyone. First of all, I'd love to thank you for tuning in to the Integrative Thoughts podcast. I am your host, Matt Kaufman, and through this platform, I plan on seeking out guests that interest me, that I am curious about, and overall just living a more meaningful, purposeful life in hopes that you as listeners and I myself can grasp onto a little bit of their knowledge and integrate that into our daily lives. Are you having trouble losing weight? Do you get extreme food cravings, especially at night? What about the inability to lose weight even when you cut calories and do a


lot of exercise? I know I fell into this category for pretty much most of my life. It's actually probably not even your fault. You most likely have what's called leptin resistance. Leptin is actually a hormone made by the fat cells that regulates food intake and energy expenditure by communicating with the brain. The more fat you have, the more negative leptin messages are actually being sent to your brain. This creates what's called leptin resistance and is going to sabotage all dieting efforts and causes food cravings even when you have enough fat stored. Introducing Zenith, this is an all new completely natural formula that gently decreases leptin levels to restore accurate communication between fat cells in the brain. Zenith contains zero harmful stimulants, it's made of all natural polysaccharides and


acetylated fatty acids, very safe for long term weight loss plans, and it is made in the USA. In an 8 week university conducted double blind placebo controlled study, participants lost 21.3 pounds of fat, lost almost 4 inches off their waistline, and reduced serum leptin levels by 43%. So if you or someone you know, someone you really love is struggling with weight loss, head down to the show notes, I'll have a link there and a few videos where you can learn more information about Zenith. So listen, I've been experimenting with different types of minerals, especially magnesium, the past 5 to 6 years. But I could never really find a product that I could feel the benefits


that magnesium claim to give. Magnesium is one of the most important minerals for all of human health. It participates in over 600 different biochemical reactions in the body, yet over 80% of the population is deficient. Magnesium deficiency can increase risk for all disease and greatly decrease optimal performance. That's why I like BiOptimizers. They use all seven forms of magnesium in a highly bioavailable form in their product Magnesium Breakthrough. Magnesium helps with stress, anxiety, sleep, immune function, detoxification, and so much more. If you want to try out this product, head over to BuyOptimizers and use code integrativethoughts10 to receive a 10% discount on their amazing product Mag Breakthrough.


Today's guest is Dr. Pinesh Jazzy.



2:54 Today's guest is Dr. Paniz Jasbi


He has a new company called Therium and the concept behind his new testing is metabolomics. And this is a concept that was kind of hard to wrap my monkey brain around. I was trying to study it beforehand, get a little grasp of what they're actually talking about, but it is a very in depth and almost esoteric type of knowledge when we're actually speaking about this on the conversation. But I do think that you could potentially get a test and get a lot of valuable information without actually understanding every little detail of metabolomics. So what this Aristotle test is, it's a metabolomics test powered by gas chromatography and mass spectrometry. And the information that you'll get back from the test includes different things like


individual metabolic profiles, some metabolite signatures, how these are associated with enzymatic and pathway functions, lifestyle factors, genetic mutations, things like that. And I'm big on detoxification and different environmental exposures. And so they have an entire panel that is dedicated to how your metabolites will react when say you have mercury poisoning like I did, or if you have radiation, maybe you work a job where you're around radiation quite a bit, maybe that'll pop up and maybe that'll explain some of the issues or symptoms that you're having. And the cool thing about this test is it gets delivered right to your home, super simple instructions. It's just a finger prick. You send it in and within a couple days, you'll get the data on the metabolomics and then


they have a bunch of AI that is going to have a bunch of scientific data in there if you kind of nerd and you want to really understand where they're getting all of their information from and then they have some action steps that you can take on the back end as well. They're not selling supplements or anything but they're just giving recommendations. So sit back, relax, enjoy the show all about metabolomics. It's a hard concept to grasp, but I do believe that this could be the future of testing.



4:48 Conversation starts


Beniz, welcome to the show. How's it going? Thank you so much for having me, Matthew. It's going pretty well. I'm really glad to be with you on the podcast today and discuss a little bit about theory and what we do. Yeah, it's a topic that Micah brought to my attention from Simply03 who I'm cool with. I've been studying health here for quite a while, and it's not really a topic that I've heard much about. So I was trying to gather some information, read your website, go through the podcast and videos he sent me, trying to get a little bit of a grasp. It definitely sounds deep and probably took you a long time to get a good understanding on it. So we'll try to knock that out the best we can in this little hour episode.



5:32 From an ASU lab to founding Theriome


So why don't you at least just tell us your background, how you got started into Ethereum. Yeah, so I guess, I mean, I don't want to go too far back in my career, but while I was completing my doctoral program at the College of Health Solutions here at Arizona University, I began to notice that there were certain disparities in what we are able to do in the laboratory at, you know, research institutes like ASU. the kind of care and treatment that patients get in their clinic, their family physician's


office or healthcare network. I noticed there was a disparity and I noticed that we could do more than we offered people. My idea was how can we synthesize and bring together recent discoveries in various fields, everything related to analytical chemistry, to physics, to bioinformatics and statistics, to technology itself. And bring all this together in a way that we can deploy incredibly advanced tools to bring unprecedented and unparalleled insights to people in a very convenient direct-to-consumer


manner. And so the idea of Therium was something that started during my doctoral training. And I founded it with my co-founder, Dr. Alex Moore, and he's a microbiome specialist. And we founded this in our post-docs, in our fellowships here, sort of as a means to realize that goal that we had in our doctoral programs, to address the gaps that that we saw for the past four years. And we thought, you know, your postdoc is a great time to, it was a great period. We were sort of building research momentum


and either, you know, transitioning into a tenure track role at a research university or you're parlaying that postdoc into a greater package at an industry job. We thought it was a great time to use that sort of momentum that we were building to found Therium. And it has become this amazing thing that we are a part of.



8:00 The Aristotle metabolomics test


And this product that we've developed, our first product, and then it was the Aristotle test. It is a metabolomics panel that monitors 126 senile aqueous metabolites that are central to human physiology and cellular functioning. And by monitoring these, we can give, you know, a 10 times improvement over the regular health tests, the normative health tests that your physicians deploy during what you would have as your yearly visit. So the idea is to use advanced testing platforms, advanced analytics to bring to you a direct to consumer dry blood spot test that yields 10 times more information than the health


information you're used to receiving. That's amazing. And before we get into- There's a lot there. There's a lot there.



8:54 Limits of standard yearly blood testing


Before we really transition into metabolomics, I wanted to pick your brain on where do you see the limitations of blood testing or just modern testing that we get at our standard doctor when we just go in and tell them we're having fatigue or whatever and they just run like a simple blood panel or even a functional lab who runs a more extensive blood panel. What are the limitations with that? with that are usually the quantity and quality of analysis. So when you go to your physician's office and they run a complete blood panel, you might get 19 parameters returned on your blood.


And those will vary from lipoproteins to liver enzymes to hemoglobin A1c. And when you return to get more advanced testing, You might get amino acids, you might get an organic acid, and these are still in number far less than what we offer with the air cell test. So that's the quantity of it. We see more things. The quality aspect comes from the fact that our data analysis is done using a Bayesian AI that has been trained on the most recent scientific data curated and manually, both


scraped AI and manually curated to compile this enormous database of functional knowledge that we have at Therium. And again, that comes from noticing this discrepancy in graduate school between what we know in the science and what is translated. And usually that bar of approval for translation is erroneous. And there are so many things that have been proven at the cellular, animal and in human levels that can be directly translated in a relative way to provide interventions or diagnostic information to our customers.


And what we've done essentially is, is compile this database, leverage it with our Asian AI, as well as the patient demographics and clinical data that they provide us. So we are able to not only analyze more, but analyze that data using very advanced methods within the context of that customer's life, including things such as their potential exposure to environmental toxins or family histories of diseases, the medications they're taking, so on and so forth, diet, nutrition. Those relevant factors, in conjunction with what we've gleaned from the literature, provide


us an incredibly tailored and personalized approach to addressing our customers' healthcare problems. One that is deeply rooted in academic scientific research and yet aimed squarely at... the customer. And this is a test that can be done at home. The results can be retrieved



12:06 At-home results and a consult with their clinicians


at home. You can schedule a consulting session with one of our healthcare providers. We have MDs, we have RDs, we have PhDs. And you can consult at home. This is a very convenient means of tapping into the deepest levels of your molecular systems. And keep in mind this is one test. We're also developing additional tests for systems levels, such as the BioMe test, which will be our upcoming long read 16S test, using a very convenient at-home stool wipe. In addition to that, we will add levels such as an LC tandem


mass spec assay for proteomics, which at that point we will start obviating the need for traditional blood panels from your physician. Since once we get to the proteomics using a new platform, a mass spec, a tandem mass spec platform, with liquid chromatography, we'll be able to separate and analyze most of the parameters that are relevant to your physician's blood testing as well. So we aim to be this sort of data and information systems monolith in the field whereby we can cater to your personalized needs, offer the most advanced


health testing platforms as well as the most advanced analysis and results reporting. Pretty soon we'll be launching our app. So you'll be able to download it via the Apple Store and interact with your results as well as our healthcare team, health and health care and science team via your phone or any sort of connected device. So the idea is to give you the most information in the most convenient way possible. Yeah, I like the sounds of that. And I mean, you don't know this about me, but I've been through the ringer with health issues and I have Lyme disease and heavy metals and all the things. And I, you know, my lab, because I was eating really clean and I was doing yoga and I was in the sauna, you know, my blood work would, they would say would look pretty normal.


I wouldn't have much to see on there. And even though I feel like I was half dead. I'm wondering had I had a test like this that could have been sent to my house in the very beginning, very easy, not spending money on this functional practitioner and the test they want and then not really getting results and going to another one and then another one, you know, I probably went through the wringer about four or five of them till I ended up out at Dr. Minkoff and got some decent results out there. I wonder what I could have seen maybe by using metabolomics. So why don't you kind of try to explain metabolomics? Like what you measuring here? I know you mentioned that you're measuring a lot more, but what is it actually measuring and how can you tell if someone has environmental toxicity or early


stage of disease, anything like that? Yeah, that is a super great question and one that comes up again and again and again and again. The idea is so applicable to conditions that affect us because some of the things some conditions, and we're going to talk about what metabolomics is and why conditions such as the ones you were going through that are sort of vague, ambiguous, hard to test for. Why would the metabolol be the ideal level of systems biology to test? So we're all familiar with genomics, right? At this point, I think we all understand that the genome is the complete set of DNA


instructions, right? Now that genome, that nuclear DNA is often transcribed. It's transcribed to RNA, right? And that RNA is sort of the coding mechanism for what is going to be expressed. So RNA expression is important. It has some functional relevance. Many RNAs have functions on their own, but most RNAs are transcribed because they're going to be translated into proteins. Now, DNA expression goes through RNA. So when we talk about the genome, we're talking about the DNA. When we talk about the transcriptome, we're talking about all that parts of the DNA


that gets expressed. Now, because of certain epigenetic factors, not all of DNA is going to get expressed, whether that's methylation, whether that's histone modification, or whether that's interference from non-coding RNAs. epigenetics as a whole will sort of affect how much of that DNA is transcribed into RNA, how much of that genome is transcribed to the transcriptome. Now when you get to the transcriptome, then you go translate and express proteins. You translate the RNA and each one expresses a protein, and that's how we think of it, right? And that itself is another level of expression. Then you have the proteome. Now all of these levels also interact with the metabolism.


The metabolism sits lowest of all of these, beneath the proteome, beneath the transcriptome, beneath the genome. And in the hierarchy of systems biology, it's nearest to the phenotype, which is especially attractive when you consider that it's also nearest to the environment. So it sits at the intersection between the genes and the environments. It is quite literally the most sensitive and attractive level to test if you're looking to test for gene environment interactions. That is really appealing now because most diseases, especially what we call the four horseman, which is cardiovascular disease, cancers, neurodegenerative diseases, and metabolic


diseases, these are essentially the four horsemen. They're all heterogeneous disorders, meaning that they're all some sort of complex mixture of genomic and environmental factors. That gene environment interaction is truly the cause of most conditions that contribute to human morbidity and mortality. Most conditions are not like, let's say, Huntington's, where the gene has incredible penetrance and a person person who has that gene, necessarily will develop and most likely die of Huntington's. That is very few diseases. and most of what we


metabolites that are consumed, expressed, or in some ways synthesized by your biology and its interactions with its environment. now there's another level that we haven't talked about yet, of course, is the microbiome, which is this 30 pound commensal organ that lives in us, on us, and it interacts with all of our levels of systems, biology from the genome down to the proteome. They themselves have their own systems levels. this very complex interaction that we are aiming to, for the first time, really compile and study in a detailed, organized, systematic way. And we do that, actually, by health testing.


That is the sort of foundation for this growing bond of knowledge. Why is it really important? Because the conditions you were describing, like heavy metal toxicity, Lyme disease, these are very heterogeneous disorders. They have very subtle but similar changes from homeostasis. So when you compare it to a lot of disorders that are in that space that would be sort of hard to differentiate between, we would potentially be able to, in our disease signature panel, find that signature for Lyme disease or heavy metal toxicity. I believe Lyme disease is in our panel, but for things like heavy metal toxicity, while


we can't look at it directly, we can get an oblique sense of what is going on. We have more than half a dozen metabolites in our panel that speak directly to environmental toxicity, and we have an index. We have 12 health indices that range from neurocognitive score, liver health, cardiovascular



20:36 Twelve health indices, including an environmental toxin score


score, aging index, mitochondrial health. One of them is an environmental toxin exposure score. I know one metabolite that we have in there is taurine. This amino acid is involved in various detoxification processes, including bile acid conjugation, which helps eliminate certain toxins from the body. We also have glutathione. This molecule is an antioxidant that plays a key role in the detoxification of harmful substances in the liver, including environmental toxins. So reduced levels could suggest increased oxidative stress, potentially due to toxin exposure. We have a panel of three metabolites in that toxin exposure index that are analyzed using elacirabrussian. Those are cystine, cystithionine, methionine.


These sulfur-containing amino acids are involved in the synthesis of glut-phion and other molecules necessary for detoxification pathways. We also have adenine, adenosine, in a scene, in guanosine. And these purine metabolites play a role in cellular energy production and risk-pair processes. So disruption in their levels might indicate cellular stress or damage potentially due to toxin exposure. We also have uric acid. And so elevated uric acid can indicate oxidative stress in the body, which could be due to environmental toxin exposure. And then finally, we have malic acid, fumaric acid, sassinic acid, and citric acid. And these components of the Krebs cycle,


also known as the citric acid cycle. These are essential for energy and cellular production of energy. So disruptions in these metabolites might indicate mitochondrial stress, which again could be response to toxic exposure. And as you can see, by analyzing these six different known pathway level associations that are related to environmental toxins, we're able to get an incredibly holistic and much more comprehensive view of that. And so if you had a very low toxic exposure score, that would immediately be a red flag as to things you should consider and something that would need your attention. And in our report, of course, we take a lot of survey data from our customers


so they can better contextualize their health scores. And so we might be able to match your metabolite profile with some of the demographic information you provided and provide really specific suggestions as to what you should do to lower your environmental toxic exposure score, Maybe that could mean from, you know, we detected that you live next to a Superfund site or it could be something that, you know, from your zip code, we detected you live next to a Superfund site. Or it could be something that we saw, hey, you have certain metabolites that are known to be related to very processed cosmetics. And so please switch your cosmetics and house cleaning products to more


organic substances or something like that. So we've had reports that have really been informative for our customers and especially the environmental toxic exposure index has been a wake up call for a lot of people it seems. Yeah, that's incredible. So let me try to run this back and see if I'm analyzing this correctly. So it sounds like there's a metabolomic score that will inherently tell you like, hey, You might have this toxicity, mercury, lime, something like that, which is interesting because I did talk to... in Mitchell this weekend and he said that he did a metabolomics and he had radiation and that I mean for him that's right on par right the wizard scientist in the lab and


so that kind of got my gears turning like okay maybe it is pretty specific and there is ways to tell but then so say you know say mine I had mercury toxicity so say that pulled up when I took a test but then you're also kind of cross referencing with some of these glutathione levels or taurine other detoxification things that can be slowed down due to the environmental toxicity, you know, as the toxicity gets higher, a lot of your levels on glutathione and other things that you need to shuttle those out tend to get tainted or they're kind of lower. That's why people do well with like glutathione suppositories and different supplementation and things like that when they're trying to detox. So it sounds like you got the metabolomics that kind of steer you in the right direction, but there's also these other panels like glutathione and


things like that you can look at to help you kind of cross reference and put it all together and say, okay, now we're looking more at an environmental exposure, right or wrong? Partially right. Okay. All right, but not... You missed a couple of things that could have made it more complete. So I just want to clear out that things like taurine and glutathione, they're not additional panels. These are metabolites and these are a part of our 126 monitored metabolites with gas chromatography and mass spectrometry. So that's the platform we use, GCMS. Um, I wish I could say it was super innovative. It's more than 50 years old. Um, I believe that the style of, I mean, it's older than that.


GCMS is older than that. Um, but the style of our analysis is about 50 years old. And, um, we are not doing anything that hasn't been already rolled out in academia and research and, and clinical mass spectrometry labs. What we are doing is sort of offering that platform, turning its power at the discretion of the end user. All of these metabolites that I've listed just now for the Environmental Toxid Exposure Index, they're all part of the 126. We monitor 126 and we report 126. What we also do is report, we multiplex them essentially.


Our environmental toxic exposure index, like I said, has six different weights and each of those weights are between one to four metabolites long. Our mutational load index has adenine, guanosine, inosine, adenosine, again taurine and glutathione and they're roped into one algorithmic weight by themselves. So we have certain calculations that are of course informed by studies that have been performed in models that have been validated for fit. And each one of these, each index, has different combinations of those 126. But we monitor all 126, and each one actually means


something. And if you go through your report, you will see the level of your metabolite, normal levels, and then also a little general description of the metabolite usually related to when it was first discovered or synthesized in the laboratory and its structure. And then we Then we give a little blurb about the implications of low levels. You can check yourself. If the world is low, you have the ranges, you have your level and you have the ranges. You can check if it's low. It gives you an information and it says, this is the implication of low levels. This has been associated with XYZ. These are the implications of high levels, XYZ. What we have done is in addition to those individual one by one results that you can


go for each metabolite.



27:42 How 126 metabolites become a 1-to-10 score


We have constructed a summary page of 12 health indices, 12 algorithms of those 126 that have been combined and weighted with various different errors included to produce a score for you that is then normalized out of 1 to 10. And we give you this score for you. You want a 1 to 10 vary from 1 being poor, 5 being neutral, and 10 being optimal for the aging index, the mitochondrial score in each indices is itself a algorithm that is compiled of various metabolites of that 126, not all of them. But they're all different.


They're all weighted differently. They're all different calculations. But they're based on that 126. Now, what we also offer is a disease signature report. This is a no means of diagnosis. But what we do is we say, you know, phenylketonuria. You have 10 metabolites that are associated with phenylketonuria. Of those 10, you had changes in seven of them, typical of people with PKU. So you have a 70% match, right? And then you have a confidence score. And that confidence score is a confidence in our analytical validity. We never report a result in which we have less than 95% confidence. The goal is to always show that you have a 70% match with DKU, confidence at 96%.


Schizophrenia, there's 26 metabolites, and you have seven of them matched in the same sort of profile. Your matches are a little bit over 33%. This is the confidence we have at 98%. We cite everything that we show to our customers. On average, depending on your results, depending on the recommendations we may give, everything is cited. So on average, our customers receive links to between 200 and 500 scientific studies, all of which have informed the calculation of their scores and the recommendations that we've offered. Hello, everyone.


First of all, I'd love to thank you for tuning into the Integrative Thoughts podcast. I'm your host, Matt Kaufman. And through this platform, I plan on seeking out guests that interest me, that I am curious about and overall just living a more meaningful, purposeful life in hopes that you as listeners and I myself can grasp onto a little bit of their knowledge and integrate that into our daily lives. So yeah, it sounds like it's a massive amount of data by the time you get all the studies if you want to look through to back it up then.


So what if you find that you don't have a really high like assurance rate on whether or not you know you can get over that 95% is that just left out of the test. you only want to show people if it's over a 95% that you're certain that it's a match? So exactly, for the disease signatures, in 95% is really our confidence. And what do we mean by confidence? It's actually a statistical measure. What it is is actually a calculation of 1 minus alpha. Alpha is your rate of type 1 error. So the rate at which you say something is true, that is not, right? It is your false positive rate. And we want to make sure that our alpha is


at least 95%. So that 95% of the time we're right and only there's about 5% where we say there could be something and there isn't. Now when you are using a health test like the Aristotle for what we call medicine 3.0, where we're no longer responding to illness, where we're no longer treating symptoms but actually engaging in a proactive effort to maintain health. Medicine 3.0. When you're engaging in something like that, you want to have... All tests are going to be skewed either toward false positives or false positives. One way or the other, they will have a bias. Testing bias, when you're looking for what we're doing, this is medicine 3.0, you want


it to be skewed towards false positives such that you are at least flagging things more proactively. case scenario, you check up on it, you follow up on it, and it's nothing. It's better to have that than to miss potentially something and have it come up later as a more serious issue. And that's the way pathology works, right? It's incredibly insidious. And so what we have developed is a means of extracting from a few drops of blood, given our very advanced detection platform, GCMS spec, which I'm very happy to talk more about, and extract incredible sensitivity levels of 126 central metabolites.


And we can construct them using the literature and our own research. We are ourselves scientists at a human research university to construct an incredibly informative and actionable bioinformatics pipeline that gets meaningful results to our customers. So that is the goal is. And we are at the intersection of industry and academia. A lot of these entities in this space that are doing health testing aren't. And that is something that we pride ourselves on. And that is something that we feel we're uniquely positioned to do as scientists is to bring those results and that wealth of data


that we've accumulated and bring it through the translational pipeline and deliver it to people. Because medicine is incomplete, our healthcare providers are ill-equipped to handle this, you know, this amazing task that they've been assigned with, which is human health. And our goal, Ethereum, is to accelerate the knowledge transfer process and get tools and interventions and research results in silico and cross-sectional as much as we can to inform better testing and better practice.


Yeah, that's amazing. And I wanted to get into as well, why is it super important to catch some of these diseases at an earlier state as opposed to when you're in your typical doctor and you're just doing a checkup and something's already in stage four? Like what's the benefits in catching it at an earlier stage? There's myriad benefits. The number one benefit, of course, is access to enhanced treatment options. The options that are available to your disposable when, let's say, something is a stage one cancer, or when you have high pathology for Alzheimer's but you have no symptoms. There are more opportunities and more therapeutic targets available at our disposal when that pathology is at an earlier stage.


So, enhanced treatment are, of course, the number one reason why you'd want to catch something early. As opposed to that, you get better disease monitoring as well. So not only can you catch it early, but we can give you the tools to keep monitoring it in a recurring fashion and do so in a really convenient and hassle-free way.



35:25 From early detection to optimizing scores


What we also feel like is important is that we're going to go beyond just catching it, but we want to go get to a point where we're all optimizing our health scores, where we're all optimizing our liver and cardiovascular and gut health scores. We had a customer. We saw their health and disease. We saw some of their reported diet. And we were able to prescribe them to eat garlic, turmeric, and honey in certain amounts for a couple of weeks. end. They did that and eight weeks later they retested. Their gut health score went from a 2 to an 8.


And so we provide people with not just a disease monitoring sort of where we're trying to sort of always be behind the ball. We want to get ahead of the ball. We want to get ahead of the curve. And not just monitor diseases, but optimize our systems biology. And that's what I think Therium, that's our mission, is to provide you this objective barometer and help you live a better life, not just a disease for your life, but a better life through the power of science. Yeah, you actually just touched on something that I wanted to get into because I was kind of talking with Micah about this over the weekend. It's like, from a just like a patient standpoint,


I order it. We'll talk about how we actually perform the test later, but like, if I order the test, okay, I get my metabolomics back, I'm looking at everything. Now, do I get a supplementation plan, a diet plan, lifestyle changes? Like what's the report do as of now? I know we said as you get more people through the program, the AI will update and like that kind of stuff will get more advanced over the next, how many ever years, but like as of right now, like am I getting a supplementation protocol, a detox protocol? What does it look like? No, no, you, you aren't getting necessarily a protocol. What you are getting is health recommendations.


And of course, these health recommendations should be conducted with the supervision of your own health care provider or one of ours which you make a contract. What we do is give, like I said, instructions of eat 50 grams of onions, honey, and turmeric. turmeric, or sorry, it was onions, honey, and turmeric, for two weeks. We can give very specific instructions as to it seems you would benefit from CoQ10 supplementation. We have given instructions such as you have lots of metabolites related to, we can test


for glycolic acid and other metabolites downstream of glycolic acid. It's a really prominent metabolite and chemical that's put into beauty supplies. So we have been able to say, hey, I would check your beauty supplies because it is the most probable route that this ends up in our system. It's not really anything else unless you're eating a ton of like sprayed fruit from the market and you're not washing it. But usually it's through beauty products and usually we see it in our female customers. And so we can say, hey, it looks like you've got a lot of glycolic acid. I would either switch to more natural beauty products or use less. We have been able to say for some of our clients, you have a lot of genetic mutations.


And we're not testing the genome, right? But the metabolome, because it is downstream of the genome, we can have a lot of predicted functional analysis that can point out almost 4,600 different SNPs or single nucleotide probably more physics, which are the most common type of mutation. And we can, that's how we calculate our mutational load. We can say, a lot of steps that are related to cancers and I would follow up regularly with a physician to check for them. Those are the types of things we can say for now. As we grow, you know, our customer base, as we grow our data systems and we train our AI on


on more instances. Right now, we're training it on here are our metadata that have been mined from publicly available studies. Here are our own data from our own studies and our own research. And we can train it on that. It's going to be less bespoke as ultimately we plan it will be when we start accumulating a critical mass of customer data. And with If that data is we're accumulating information on the customer, we're associating it with the changes we see in the metabolome, in the microbiome, proteome, etc. And we're able to then give you better recommendations based on what associations and what our data


are telling us is the best. So given what other people have done and what we've seen has moved the needle on certain indices, we're able to give you more bespoke recommendations. But as of now, although some of the recommendation may seem vague or a little too innocuous, like make sure you're getting enough sleep, that could be because we're seeing a lot of metabolites related to neurological debris that isn't getting maybe cleared, for instance. So sleep could be a viable recommendation. And sometimes it's very specific, such as we see you're using health products with a a lot of glycolic acid, stop doing that, or co-Q10 enzyme supplementation.


So sometimes it's granular and it's getting to be more granular. And sometimes it's, you know, incorporate more cruciferous vegetables in your diet, which is always a good recommendation. So that is probably what Myco was referring to as the AI grows. We'll be able to offer more bespoke recommendations, specific interventions, specific protocols and that will be what the promise of personalized medicine should be. Yeah, no, that's great. And honestly, the protocols, one thing I think on it, actually some of the people may just


need to hear, they probably follow some health accounts on Instagram, they know that their beauty products are toxic, but they just don't give them up or it's more expensive to change out but if they get a test like this and it shows specifically this you know substance that's used in their hair products or their beauty products then you know sometimes that's what humans need a lot of times they need a little wake up call and a little bit of data right in their face. It's like a lot of times you can do some health protocols based off symptoms but people don't want to make the change unless they can see kind of like something like I like to use hair tests and you can see like the mineral patterns move or you can see the heavy metals get shifted out on some of those. And people like those because it gives them data, gives them something to look forward


to or just something to at least to kind of validate what the practitioner is talking about because as humans, we just kind of think, well, we're all good. Let's keep pushing. I'm all right for now. But you know, when you get a nice test like this, it's easy to use. It'll give them a little wake up call. Yeah, for sure. And this is something that you touched on earlier. People need to see it. They need that data. And I remember when the first continuous glucose monitors were coming out, the ones that were just a few credit cards, when they first started developing, you couldn't get them here. I'm not sure if you can't know. People were ordering them from Europe.


They were attaching them. they have that F and they would see such a massive glycemic response over the meals they were eating that while before they would probably eat that and think this is going to be fine, they were realizing that it was a real shock to their metabolism and that their bodies were in all respects as far as scientific metrics, were struggling to deal with that glycemic load. And it really changed eating patterns for a lot of those people. And then you've got the other camp and they're smaller camp, but they're the camp that like feel a certain way, I want to do something and see how it


feels and yeah that sort of personal empiricism works for a lot of people. We're not offering necessarily treatments. Our goal is to give you the most reliable healthcare monitoring. We're not selling you a test with our left hand, selling supplements with our right. We are only selling you access to your own health information and at a level in granular detail, well beyond anything that is currently not reserved for CEOs of Fortune 500 companies or dictators. So it is the essentially, it is the sort of the CEO package that we are sort of executive healthcare plan that we are aiming to


green to consumers via Ethereum and give them power and access and autonomy and control and transparency over that data. Yeah, I get that. And I see it could be conflicting to some people if you are running a test on one hand and then also you have like a supplement company where you're like, and take these supplements and we're making more money on the back end, which I really don't see a problem with. I think if there's like a problem and you have the solution, it's good. But I think some people find that as like sales mini or whatever. So maybe it's good that you just stick to the metabolomics and the testing and then you can work with one of your providers or your own provider or whatever and figure out like a some type of plan or lifestyle change or sleep habit change,


whatever that may be, that the test indicates that you need. So that might be a good route for you guys, honestly. Yeah, that's something that that we've, you know, my co-founder and I have always discussed is maintaining the sort of analytical integrity of what we do. Our goal is to essentially create the human atlas. If we have 30,000 active users and we have genomic transcript, domicocodeal, microbiomic, tabulomic data on them, and many of those tests we have serial samples from, so longitudinal data across time. And we also have collected a wealth of metadata


and demographic information to serve as adjusting variables for that data. Then we have essentially created what we have been calling the human atlas. And that sort of body of knowledge would, for the first time, allow us to answer the most pressing scientific and medical questions. And if not answer them, then at least suggest incredibly detailed studies at the molecular level, mechanistic studies that could confirm or deny what we would see as associations in our data.


And that atlas would really drive a vertical advancement in science and medicine. And ultimately, that is the goal of Ethereum. is to, of course, we make profit on our testing services. We have developed incredibly advanced testing platform, incredibly advanced bio analytics platform, and they're in the stages of developing a first of its kind data system storage platform. And so we are innovating on multiple fronts, and we are making money off of that. What is more important to us, though, is the scientific research and advancing patient care, which is what this data should be used


for. It is what this data must be leveraged for if we are going to see the promise of personalized medicine realized. And that is why we focus on the marriage between advanced bioinformatics, Bayesian artificial intelligence, coupled with advanced laboratory testing platforms such as mass spectrometry or next generation sequencing. Yeah, I mean all that sounds great and I want to get into kind of how it works. It seems super easy from the videos that I've watched. It's basically you just order the test online, right? And then it comes home. So why don't you walk us through like how much the test costs and how you easy it is to kind of just do at home.


Right. So the test is currently running for $830. If you do use a code, which I'll share with you, test me. No space, just one word, test me. If you use test me, you will get $331 off, so the test will cost $499. And that is just a limited promotion we're running for the next few weeks until we shore up a few other things. What happens is you order your test,



48:29 How the dry blood spot kit works at home


you get a shipping confirmation when it goes out. We ship usually next day, and you receive your package, at least if you're ordering within the states, a few days from then, some of our international customers takes maybe a week. You get your package and you unpack your drive blood spot test, when you open up the package, you'll see some graphical instructions that show with graphics, how to take the dry blood spot test. You'll take the components out of the testing kit. Inside that testing kit, you'll see some text instructions to accompany you. As well as a QR code, you can scan to look up our YouTube video to see how this testing procedure works.


Sorry if you use a banging sound, they're literally breaking up concrete out of our research. So, down the hall of Phoenix, it's crazy. So what you do is you take the safety lancet, and first you will wipe your finger with an alcohol wipe. You'll take the safety lancet, you'll prick your finger. You'll drop a few drops of blood onto our proprietary filter paper. And on that filter paper, we've demarcated with two dashed circles where you should place and fill up your dry blood sample. It's very straightforward and intuitive. Most people figure it out without looking at the instructions, but they're there in case you do that. You put your two blood spots on the card, you let it dry for, I believe, two hours,


as the instructions say, and then you will put that in the biohazardous aluminum foil bag with a desiccate pouch inside of it that will maintain metabolite integrity for up to two months. So it will definitely get to our lab and be processed by then. Depending on how fast you receive, take and send back your kit, your results, and that aluminum bag. You could be looking at a turnaround time of less than a couple weeks. When we receive your sample in our lab, it takes roughly 72 hours to process your sample


and report your results and generate your report to you. What we do is we first take your dry buzz box sample and we punch out a very precise amount of that sample using our biopsy punch. We then take that dry blood spot sample and we homogenize it in our chemical solvents. And then we extract the aqueous layer from that chemical solvent. We then sonicate that to make sure that any metabolites that are still bound to that paper matrix are released from that paper matrix. And then we centrifuge to separate the solid and liquid phases.


We take that liquid phase, we will essentially dry the metabolites and then derivatize them to volatilize them for analysis with gas chromatography. And gas chromatography of GC is a type of chemical analysis that requires the analysis of volatile compounds. So that's why the chemical deurification process is there. And then we have chromatography mass spectrometry that is capable of detecting metabolites at the pico molar or sometimes even femtomolar levels. So very, very low levels can even be detected and has a very wide dynamic range. So it provides an ideal platform for enhanced sensitivity.


And because we're using chromatography coupled to mass spectrometry, we're able to separate our metabolites along two dimensions. The first being retention time, or the time it takes those metabolites to chemically interact with, dissociate, and elute from the column, as well as the mass to charge, which is the molecular weight of the fragments we see on the mass spectrum. By combining these two different separation techniques and separating them twice, we're able to get incredible sensitivity and confidence that what we're seeing is the metabolite of interest. Because of the sensitivity and specificity of the platform, we're able to give unparalleled


accuracy and depth of information because these are not platforms that are, keep in mind Matthew, these are not platforms that are used in doctor's offices, in healthcare systems usually. I know that for instance the Mayo Clinic has a mass metrometry core, but that is not to be expected in most healthcare settings. This is a very, usually it's very large pieces of equipment that take up considerable footprint. also require highly advanced people to run them, such as PhDs, such as myself. And so it's not necessarily a platform that is readily deployed and only in sort of the most advanced healthcare settings where you find a mass spectrometry core or clinical mass spectrometry lab.


And that's what we do. Yeah, I love it. And it seems super simple. I feel like even someone like my mom, like she's just like, we'll never see a doctor, I feel like I could probably get this into her house and get a blood prick. She's just kind of old West Virginia, you know, just kind of stubborn. She's getting older, smoked her whole life and still doesn't care to go see a doctor. And I'm like, I don't know if I'm ever even going to be able to get her to see a doctor. But I was telling Micah, maybe I could ship her over one of these one day and just like get some, you know, see what kind of data we can get a result of a couple finger pricks. I don't think she's ever going to go in and maybe we can detect some early.



54:06 How often to retest


I wanted to know also like, so say some how often like I would imagine like someone if I'm like healthy, I'm biohacking, I'm saunaing, I'm taking all the supplements, mine might be a little basic, not too much to see. I mean, potentially still could be something there. But like, you know, would you retest yearly to trying to kind of optimize? And if you have like something more chronic, like the gut thing you were talking about, maybe test more frequently to see if some of these metabolize shift. Like, how does that work? So if you are trying to treat such or using it for regular health monitoring, I would suggest one to three times a year. That would probably be, you know, we've had customers that have ordered four so far.


They've come, like four is the most any customer has ordered. We've got a handful who have ordered up to four. And I, from what I understand, those customers are biohackers. And so they are putting interventions in and out on a regular basis. And they want to get direct snapshots of those dynamic changes in a sequential, easy to use, convenient manner. And so the Aristotle is the ideal platform for that because we give them fast results reporting, we give them a great objective barometer as to what they're doing, and so they're able to adjust and improve as the indices recommend.


Now, those are the biohackers who have ordered four in, let's say, three months. That is wonderful. It is still scientifically informed in the sense that the metabolism, the genome doesn't really change. Your proteome is very slow to change. Your gut microbiome is, for the most part, pretty resistant to change. Your metabolism is so sensitive, so dynamic, and can change so drastically from hour to hour depending on things you may have experienced or encountered, let alone from week to week


as people are adding or subtracting various components of their personalized interventions. So for those people, yeah, it might be worthwhile to test four times in three months. For people who are using this as remote health monitoring, and I've got to admit, I'm kind of like your mom. I do not like going in for the health tests. I did end up making a product that I wanted to use, like something that is like the Amazon model where I just like send it to my door, I boom, boom, boom, I put it in my mailbox and it just USPS picks it up and takes it away and then I get an app and it tells me if something's happening and if it is and I wanna follow up, I can schedule right there.


I literally have endeavored to create something that I myself wanted to see in the world, because I am a little bit delinquent in addressing my own health testing needs. And so recently, I've gone in for my own test and I take the Aristotle all the time. But I see a world where that's going to change. And I do believe ultimately that people like your mom and all these people who want to do remote monitoring should be taking it about once a year, up to three times a year if you


have family histories of certain conditions. If you have known, let's say, occupational exposure, that may be occupational exposure to certain health hazards, your toxins or radiation in the case of iron. And you want a little bit more active about it. You may take it up to three, four times a year. But it is all dependent on what you are trying to monitor and how often you're changing things and how much information you want to receive. Yeah. I didn't even think about the crazy biohackers doing one every two months, every time they add in two more supplements or subtract and see what happens. It's pretty funny.


someone do, I don't know what they did, but they did something and then they did two in one day, something in the morning, and then they did a bunch of other stuff. And then they took one late at night. And they were, in many ways, appreciably different. That fast, huh? Yeah, and many of the indices had had remained the same. But I believe half the indices went up or down by one. And the disease signatures were fairly unchanged. And the The recommendations we gave them had changed based upon the AI input. And so that customer seemed to find meaning in it because he has since ordered one more.


So we're happy to do that. That is the goal and the purpose of this very convenient direct-to-consumer advanced health testing service. Yeah, that's cool. And they're helping to play into the research, obviously, of it. And I would imagine the biohacker could have done a lot of things to shift. There's so many things we can do with the technologies, the IVs. I mean, he could have done just a multitude of things to shift that in that manner that most people don't have access to or wouldn't do. I was at the biohacking conference. I was like, I'm like 10 different new supplements that were unreleased. And I was on this device in the $150,000 immortal bed


and then the flow press. So I'm like, I really, I don't even know what's working at this point. I'm on 10 different supplements and I've been in three different biohacks in the last four hours. Yeah. Yeah. And that's something that, you know, for us on the data end, we want to try to get as much information from our customers as possible because all those... interventions could potentially be confounding noise to what we can see in the data, but a lot of it is up to you. So you're doing a biohacking. If your cardiovascular score is low, you might do a certain hack to increase that. You might do a certain ID therapy to increase that. If your liver score is low, you might do something to increase that. Your gut health score, there's a certain set of interventions.


And so from what I understood, what I was told was this person had essentially targeted. Our recommendations were good and they had built off that and targeted certain other things they were going to incorporate and had done that and wanted to see the effects on their scores later that same day. And so again, it must have been okay because you were such another task. Yeah, we're really excited. Whether your health journey is, I haven't been to a doctor in years. I'm a little overwhelmed. And I'd like to do it in a convenient, comfortable manner. Or maybe your health journey is,


I am well ahead of my own health. I am now back biohacking into new spaces, and I'm optimizing. And I want to maximize my health span, my longevity, and whatever I've got left. We have customers on both ends of the spectrum. And the great thing about unbiased, you know, highly advanced information that we're giving is, is it's applicable to both cases. And it's, it's highly advantageous to, to anyone who has a body. And if you have a body, this is, this is a product for you. And, and hopefully, you know, what we are


trying to do is again, synthesize these disparate innovations and everything from remote sample collection to analytical chemistry, to bioinformatics, and, and as well as technology, you know, app development and bring this together in one package to help the end user and give them a tool that is for now reserved only for the upper echelons of academic research. Yeah, that's incredible. I'll be interested to keep in contact with you guys and see how the data shifts over time. I know we only got a few minutes left and you kind of spoke about this new gut testing. I know everyone uses myVyome and people use gimap in different ways to try to test for parasites


or different bacteria, candida, all of the things. How is your gut test gonna be different and when will that be released? Yeah, so our gut tests, we have one coming out is a long range 16S test. We also have one that is shotgun transcriptomics. So in the case of shotgun transcriptomic testing, it is the most advanced testing And we're able to get species-level resolution on more than 700 entities. So that could be bacteria, various archaea, fungi, et cetera. And so we have, again, the differences in quantity and quality of analysis.


The number of features we're able to detect at level seven resolutions. the highest-risk species of a resolution. That is about four orders of magnitude greater than our closest competitor. In addition to that, we're using an advanced AI engine, one that has a significant amount of research and development, academic research and development peer review publications behind it. In addition to that, we are implementing this amazing integration between every system's


double test we offer. The gut bacteria account for so much of a smaller proportion of variance than your metabolal or your genome and so as we build these tests it's not so much the information we're getting from each individual tests but the cumulative information we're getting from integrating and synergizing those results. Your bacteria have this direct relationship with the production and consumption of your metabolites. If we have a customer that has both of their levels of data with us, then the report we're able to generate is going to be far more personalized, far more actionable and meaningful because not only do we have now with our test the


relative composition of various species of bacteria in your gut, will now have a direct functional readout of their fluxes, of their metabolite fluxes, their relative consumption and production of known metabolites. We also have a highly multiplexed array in which we have begun in silico to simulate the interactions between over a thousand metabolites and 435 bacterial strains. We're able to simulate their predicted productions and consumptions of metabolite levels.


So we're able to do relative flux analysis, we're able to accomplish co-current analysis via a software known as MMVec and ultimately provide you with a much more holistic snapshot, not just what's in there. Most of these tests are reporting just what's in there. They're not reporting what they do. And what we are reporting with the combination of our Aristotle and our upcoming Bio-Knee test is here are your gut bacteria and here's all the information associated with it in a much more complete way than anything that's out there. But we're also going to tell you not just what's there in the composition, but the functional relevance of those bacteria and what they are or are not doing.


Ultimately, that's what's going to guide actionable interventions to change your health score from where it is to where you want it to be. And that's not something that is currently done by any other entity. We are, at the heart of us, we are a multi-omics testing platform. And it's only by expanding to all levels of systems biology that we will be able to offer the most advanced snapshot of a person's molecular biology, which is ultimately one of the greatest determinants of health. We are expanding that. And by offering the Bio-Me test in conjunction with the Aristotle's test, we completely


set ourselves apart from other testing entities because we're not, again, just telling you what's there, what bacteria and bion are there in your gut, but what are they doing? And once we have that, we can tell you what you should do to influence those metabolite, microbiota interactions. Yeah, I think it makes total sense. And a lot of times, you know, circling back around to like the environmental exposures, I know that I've dealt with this is a lot of times the gut function is directly correlated with some of those like mercury toxicity and different environmental exposures. So I wonder if there'd be a way to kind of You look at it and be like, yeah, here's the toxicity on the metabolomics. And then also here's the gut dysfunction as well, which is basically a lot of times


associated with the same environmental toxin that we're showing on the metabolomics. Yeah, exactly. Yeah. And so we provide this, again, this direct functional readout, this output that shows us what is being expressed from the genome, what is being expressed and consumed from the microbiome. And by providing that layer, that metabolomics layer, which is again the most sensitive nearest to the phenotype, we're able to modulate differentially our recommendations for our customers based upon their specific makeup and profile of all the levels above metabolomics. And so as we build this out, we will start to offer a very compelling health status report


and one that we feel like is vastly greater than in every way, amplitude to current testing efforts.



1:08:16 Where to find Theriome


Awesome, man. Well, thank you so much for coming on the show and explaining metabolomics to someone who has no understanding really of metabolomics and is trying to just figure it out as I go. Why don't you tell everyone where to find you, how to find the website, how to order a test, anything like that? Sure. If you'd like to learn more about theorem or order a Aristotle test, please visit www.therio.me. That is T-H-E-R-I-O.me. If you would like to learn more about us, please message info at therio.me. Again, that's T-H-E-R-I-O.me. And if you'd like to send me an


email with any questions you may have, please email me at jasbyjasbi at therio.me. Thank you Matt so much for having me on. I hope to stay in touch as we continue our journey here. Absolutely, man. We definitely will. I told Micah maybe one day, he was kind of like, if you're healthy, it might not show much. I might just grab a test at some point and if I do, maybe we'll come back on and we'll go over the data or something. Sure. And keep in mind the limited promotion we're running for, I think the next two weeks, maybe one week, I don't know. My co-nodes more about that is test me. So if you use test me as a code on our website, you'll receive $331 off.


So the test will be $499. So I will preface this that the episode probably won't be out for a few weeks. So that code may or may not be. May or may not. Right. So don't give your hopes up. $130. Yeah. Price is $830. Thank you for preface that. Yeah, I just wanted to make sure because I heard it on Matt's show, but usually they're pre-recorded. They don't come out for a few weeks. So we'll see. Maybe the code will work. Maybe it won't. We'll see. And I hope it does for everyone. And if you guys have any questions or experience any issues, again, please email us at the address, as I mentioned. And I hope people listening found this valuable and found it informative and maybe it could be a gateway to optimizing their health journey.


So thanks so much, Matthew. Yeah, thank you. Have a great day. Bye-bye. If you enjoyed this show, would you please take a second to subscribe, rate, and review it for me. Also, if you'd like to know more information about combo, personalize one-on-one coaching with me, or for upcoming retreat information which I host with my wife, please visit my website in the show notes or DM me on Instagram. My handle over there is at integrativematt. Until next time, my friends.



About the people in this episode


Dr. Paniz Jasbi


Guest, founder of Theriome


Dr. Paniz Jasbi founded Theriome after doctoral work at Arizona State University's College of Health Solutions. The company offers at-home metabolomics testing, starting with the Aristotle dry blood spot panel, and is building additional assays. He points people to therio.me and info@therio.me.



Matthew Coffman


Host of Integrative Thoughts


Matthew Coffman is the host of Integrative Thoughts, a show on mineral balancing, HTMA, and practical health education, with over 100K downloads. He works with clients on mineral balancing online.









Questions answered in this episode


Who is Dr. Paniz Jasbi?


Dr. Paniz Jasbi is the founder of Theriome. In the interview he describes completing his doctoral program at the College of Health Solutions at Arizona State University and starting the company to close the gap between research-lab testing and ordinary clinic panels.



What is the Aristotle test?


Paniz describes it as Theriome's first product: a direct-to-consumer dry blood spot metabolomics panel, run with gas chromatography and mass spectrometry, that monitors 126 metabolites central to physiology and then reports them both one by one and as 12 scored indices.



What do the 12 health indices cover?


He lists scores that include neurocognitive, liver, cardiovascular, aging, mitochondrial, gut, and environmental toxin exposure. Each index is an algorithm built from a subset of the 126 metabolites and is normalized on a 1-to-10 scale, with 1 described as poor, 5 as neutral, and 10 as optimal.



Can you do the test at home?


Yes. He says the kit is shipped to you with graphic and written instructions plus a QR code to a video. You collect a dry blood spot, send it back, review results at home, and can schedule a consult with one of Theriome's MDs, RDs, or PhDs.



How often does he suggest retesting?


For regular monitoring he suggests one to three times a year. He notes some customers, often people who are already tracking closely, have ordered as many as four tests.



Where can you learn more or order a test?


Paniz points people to therio.me, spelled T-H-E-R-I-O.me, and to info@therio.me. He also mentions upcoming tests such as BioMe, a stool-based assay still in development at the time of the recording.




Affiliate link: I may earn a commission.

 
 
 

Comments


bottom of page